ClassID:

97290

C07K2317/626 - page 3 - CPC Classification

Classification description:

Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components Diabody or triabody

Recent Application in this class:
#601
20070093651
2007-04-26

Ligand

#602
20070077624
2007-04-05

Recombinant production of mixtures of antibodies

#603
20070077249
2007-04-05

Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor

#604
20070054362
2007-03-08

Recombinant production of mixtures of antibodies

#605
20070004909
2007-01-04

Covalent diabodies and uses thereof

#606
20070003977
2007-01-04

Epitope protection assay and method for detecting protein conformations

#607
20060287509
2006-12-21

High affinity human antibodies to tumor antigens

#608
20060275301
2006-12-07

Cell death-inducing agent

#609
20060269989
2006-11-30

Process for producing antibodies

#610
20060251668
2006-11-09

Tumor-specific recognition molecules

#611
20060246517
2006-11-02

ALS-specific peptide composition

#612
20060233787
2006-10-19

Human cd3-specific antibody with immunosuppressive properties

#613
20060228364
2006-10-12

Serum albumin binding peptides for tumor targeting

#614
20060222643
2006-10-05

Anti-MPL antibodies

#615
20060210564
2006-09-21

Diabody-type bispecific antibody

#616
20060127357
2006-06-15

Rapamycin and il-10 for the treatment of immune diseases

#617
20060115470
2006-06-01

Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders

#618
20060106203
2006-05-18

Ligand

#619
20060073141
2006-04-06

Compositions and methods for treating inflammatory disorders

#620
20060063921
2006-03-23

Ligand

#621
20060063715
2006-03-23

Multivalent antigen-binding proteins

#622
20060034845
2006-02-16

Single domain antibodies directed against tumor necrosis factor alpha and uses therefor

#623
20060034833
2006-02-16

Single domain antibodies directed against interferron-gamma and uses therefor

#624
20060002935
2006-01-05

Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor

#625
20050282233
2005-12-22

Multivalent antibody materials and methods for VEGF/PDGF family of growth factors

#626
20050244333
2005-11-03

Humanized anti-CEA T84.66 antibody and uses thereof

#627
20050232931
2005-10-20

Preparation and application of anti-tumor bifunctional fusion proteins

#628
20050226882
2005-10-13

Method and multicomponent conjugates for treating cancer

#629
20050176934
2005-08-11

Antibody combination useful for tumor therapy

#630
20050170398
2005-08-04

Recombinant production of mixtures of antibodies

#631
20050158322
2005-07-21

Specific antibody fragments for the human carcinoembryonic antigen (cea)

#632
20050142539
2005-06-30

Targeted ligands

#633
20050118164
2005-06-02

Targeted ligands

#634
20050089519
2005-04-28

Bispecific anti-cd19x anti-cd16 antibodies and uses thereof

#635
20050069549
2005-03-31

Targeted ligands

#636
20050059053
2005-03-17

Complex formation for the stabilisation and purification of proteins of interest

#637
20050037339
2005-02-17

Methods of selecting internalizing antibodies

#638
20050004352
2005-01-06

Single-chain multiple antigen-binding molecule, its preparation and use

#639
20050003403
2005-01-06

Polyvalent protein complex